Summit Therapeutics, Inc. (SMMT)
17.71
+0.41
(+2.37%)
USD |
NASDAQ |
Sep 17, 16:00
17.71
0.00 (0.00%)
After-Hours: 20:00
Summit Therapeutics Total Return Level : 17.30 for Sept. 16, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 16, 2026 | 17.30 |
| September 15, 2026 | 17.40 |
| September 14, 2026 | 18.42 |
| September 11, 2026 | 17.55 |
| September 10, 2026 | 17.00 |
| September 09, 2026 | 17.54 |
| September 08, 2026 | 17.28 |
| September 04, 2026 | 17.60 |
| September 03, 2026 | 17.13 |
| September 02, 2026 | 14.60 |
| September 01, 2026 | 14.16 |
| August 31, 2026 | 13.62 |
| August 28, 2026 | 13.73 |
| August 27, 2026 | 14.33 |
| August 26, 2026 | 14.23 |
| August 25, 2026 | 13.36 |
| August 24, 2026 | 12.73 |
| August 21, 2026 | 13.16 |
| August 20, 2026 | 12.43 |
| August 19, 2026 | 13.11 |
| August 18, 2026 | 12.82 |
| August 17, 2026 | 12.78 |
| August 14, 2026 | 13.35 |
| August 13, 2026 | 14.00 |
| August 12, 2026 | 15.10 |
| Date | Value |
|---|---|
| August 11, 2026 | 15.12 |
| August 10, 2026 | 14.87 |
| August 07, 2026 | 13.96 |
| August 06, 2026 | 13.54 |
| August 05, 2026 | 13.53 |
| August 04, 2026 | 13.76 |
| August 03, 2026 | 13.04 |
| July 31, 2026 | 13.02 |
| July 30, 2026 | 13.44 |
| July 29, 2026 | 12.80 |
| July 28, 2026 | 12.55 |
| July 27, 2026 | 13.10 |
| July 24, 2026 | 13.66 |
| July 23, 2026 | 14.98 |
| July 22, 2026 | 14.74 |
| July 21, 2026 | 14.63 |
| July 20, 2026 | 13.50 |
| July 17, 2026 | 13.81 |
| July 16, 2026 | 13.76 |
| July 15, 2026 | 15.07 |
| July 14, 2026 | 15.47 |
| July 13, 2026 | 15.30 |
| July 10, 2026 | 15.25 |
| July 09, 2026 | 15.48 |
| July 08, 2026 | 15.69 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| NovelStem International Corp. | 0.0129 |
| Brainstorm Cell Therapeutics, Inc. | 0.9790 |
| Kezar Life Sciences, Inc. | 7.29 |
| Protara Therapeutics, Inc. | 3.62 |
| Clene, Inc. | 3.86 |